Key Takeaways TMO acquired Solventum's unit for $4.1B and Olink to expand biologics and proteomics capabilities. TMO's recent product launches include CorEvitas AA Registry and EVOS S1000 Spatial Imaging System. Thermo Fisher faces ongoing macroeconomic and currency headwinds that may impact profitability.Thermo Fisher Scientific Inc. (TMO) focuses on expanding through the acquisition of technologies and businesses that augment its existing products and services. The company continues to enhance its portf ...

STERIS plc’s (STE) Healthcare business continues to benefit from robust U.S. procedure volumes, favorable pricing and market share gains. Service revenues fuel the Applied Sterilization Technologies (“AST”) segment’s growth. Moreover, sound financial health bodes well for the stock. Meanwhile, macroeconomic challenges and adverse currency impacts appear concerning for the company’s operations. In the past year, shares of this Zacks Rank #3 (Hold) company have advanced 10.4% against the industry’s 10.4% fall ...